Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2005 12
2006 9
2007 12
2008 10
2009 8
2010 4
2011 9
2012 14
2013 12
2014 11
2015 7
2016 10
2017 9
2018 7
2019 13
2020 15
2021 13
2022 16
2023 9
2024 14
2025 17
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.
Tamura T, Irie T, Deguchi S, Yajima H, Tsuda M, Nasser H, Mizuma K, Plianchaisuk A, Suzuki S, Uriu K, Begum MM, Shimizu R, Jonathan M, Suzuki R, Kondo T, Ito H, Kamiyama A, Yoshimatsu K, Shofa M, Hashimoto R, Anraku Y, Kimura KT, Kita S, Sasaki J, Sasaki-Tabata K, Maenaka K, Nao N, Wang L, Oda Y; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ikeda T, Saito A, Matsuno K, Ito J, Tanaka S, Sato K, Hashiguchi T, Takayama K, Fukuhara T. Tamura T, et al. Among authors: maenaka k. Nat Commun. 2024 Feb 8;15(1):1176. doi: 10.1038/s41467-024-45274-3. Nat Commun. 2024. PMID: 38332154 Free PMC article.
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, Begum MM, Uriu K, Mizuma K, Nao N, Kojima I, Tsubo T, Li J, Matsumura Y, Nagao M, Oda Y, Tsuda M, Anraku Y, Kita S, Yajima H, Sasaki-Tabata K, Guo Z, Hinay AA Jr, Yoshimatsu K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Nasser H, Jonathan M, Putri O, Kim Y, Chen L, Suzuki R, Tamura T, Maenaka K, Irie T, Matsuno K, Tanaka S, Ito J, Ikeda T, Takayama K, Zahradnik J, Hashiguchi T, Fukuhara T, Sato K; Genotype to Phenotype Japan (G2P‐Japan) Consortium. Tsujino S, et al. Among authors: maenaka k. Microbiol Immunol. 2024 Sep;68(9):305-330. doi: 10.1111/1348-0421.13165. Epub 2024 Jul 4. Microbiol Immunol. 2024. PMID: 38961765 Free article.
Structural basis of the hepatitis B virus X protein in complex with DDB1.
Tanaka H, Diogo Dias J, Jay B, Kita S, Sasaki M, Takeda H, Kishimoto N, Sasaki S, Misumi S, Mizokami M, Neuveut C, Sumikama T, Shibata M, Maenaka K, Machida S. Tanaka H, et al. Among authors: maenaka k. Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2421325122. doi: 10.1073/pnas.2421325122. Epub 2025 Jun 13. Proc Natl Acad Sci U S A. 2025. PMID: 40512786 Free PMC article.
Structural basis for receptor-binding domain mobility of the spike in SARS-CoV-2 BA.2.86 and JN.1.
Yajima H, Anraku Y, Kaku Y, Kimura KT, Plianchaisuk A, Okumura K, Nakada-Nakura Y, Atarashi Y, Hemmi T, Kuroda D, Takahashi Y, Kita S, Sasaki J, Sumita H; Genotype to Phenotype Japan (G2P-Japan) Consortium; Ito J, Maenaka K, Sato K, Hashiguchi T. Yajima H, et al. Among authors: maenaka k. Nat Commun. 2024 Oct 7;15(1):8574. doi: 10.1038/s41467-024-52808-2. Nat Commun. 2024. PMID: 39375326 Free PMC article.
HLA-G molecule.
Kamishikiryo J, Maenaka K. Kamishikiryo J, et al. Among authors: maenaka k. Curr Pharm Des. 2009;15(28):3318-24. doi: 10.2174/138161209789105153. Curr Pharm Des. 2009. PMID: 19860681
Structural characteristics of measles virus entry.
Fukuhara H, Mwaba MH, Maenaka K. Fukuhara H, et al. Among authors: maenaka k. Curr Opin Virol. 2020 Apr;41:52-58. doi: 10.1016/j.coviro.2020.04.002. Epub 2020 May 12. Curr Opin Virol. 2020. PMID: 32413678 Review.
Molecular basis for selection and inhibition of HIV-1 escape virus by T cells and KIR2DL2+NK cells.
Chikata T, Kuroki K, Kuse N, Kliszczak AE, Paes W, Tomioka N, Parker R, Aflalo A, Akahoshi T, Zhang Y, Yamashita R, Sakata R, Kusaka H, Watanabe Y, Nicastri A, Matsubara H, Ose T, Kita S, Oka S, Gatanaga H, Lin Z, Ternette N, Borrow P, Maenaka K, Takiguchi M. Chikata T, et al. Among authors: maenaka k. Nat Commun. 2025 Nov 6;16(1):9796. doi: 10.1038/s41467-025-64768-2. Nat Commun. 2025. PMID: 41198628 Free PMC article.
Evolutionary and structural basis of SLAMF1 utilization in morbilliviruses-Implications for host range and cross-species transmission.
Hyodo A, Seki F, Fukuda K, Tashiro K, Kitai Y, Akahori Y, Watabe H, Katoh H, Osaki R, Takaya D, Kawashita N, Fukuhara H, Ikegame S, Yoshikawa T, Eunsil P, Morikawa S, Yamaguchi R, Lee B, Maenaka K, Shirai T, Fukuzawa K, Tanaka S, Takeda M. Hyodo A, et al. Among authors: maenaka k. PLoS Pathog. 2025 Jun 10;21(6):e1012990. doi: 10.1371/journal.ppat.1012990. eCollection 2025 Jun. PLoS Pathog. 2025. PMID: 40493685 Free PMC article.
223 results